Overexpression of SIRT3 disrupts mitochondrial proteostasis and cell cycle progression

doi:10.1007/s13238-016-0251-z

Protein Cell

2016, Vol. 7

Issue (4) : 295-299 https://doi.org/10.1007/s13238-016-0251-z

LETTER

Overexpression of SIRT3 disrupts mitochondrial proteostasis and cell cycle progression

Xiaofei Wang¹,Haiping Tang¹,Yuling Chen¹,Binghuan Chi²,Shiyu Wang³,Yang Lv³,Di Wu³,Renshan Ge²,Haiteng Deng^1,^*(

)

1. MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing 100084, China
2. Wenzhou Medical College, Wenzhou 325035, China
3. Center of Nephrology, The General Hospital of the PLA, Beijing 100853, China

Download: PDF(581 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Corresponding Author(s): Haiteng Deng

Issue Date: 09 May 2016

Cite this article:

Xiaofei Wang,Haiping Tang,Yuling Chen, et al. Overexpression of SIRT3 disrupts mitochondrial proteostasis and cell cycle progression[J]. Protein Cell, 2016, 7(4): 295-299.

URL:

https://academic.hep.com.cn/pac/EN/10.1007/s13238-016-0251-z
https://academic.hep.com.cn/pac/EN/Y2016/V7/I4/295

1	Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL (2011) SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta 1816:80–88
2	Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD, Shiels PG (2006) Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer 95:1056–1061 https://doi.org/10.1038/sj.bjc.6603384
3	Carracedo A, Cantley LC, Pandolfi PP (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13:227–232 https://doi.org/10.1038/nrc3483
4	Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353:2477–2490 https://doi.org/10.1056/NEJMra043172
5	Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT (2010) Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer 9:180 https://doi.org/10.1186/1476-4598-9-180
6	Finley LW, Haigis MC (2012) Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med 18:516–523 https://doi.org/10.1016/j.molmed.2012.05.004
7	Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17:41–52 https://doi.org/10.1016/j.ccr.2009.11.023
8	McDonnell E, Peterson BS, Bomze HM, Hirschey MD (2015) SIRT3 regulates progression and development of diseases of aging. Trends Endocrinol Metab 26:486–492 https://doi.org/10.1016/j.tem.2015.06.001
9	Papa L, Germain D (2014) SirT3 regulates the mitochondrial unfolded protein response. Mol Cell Biol 34:699–710 https://doi.org/10.1128/MCB.01337-13
10	Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12:662–667 https://doi.org/10.1016/j.cmet.2010.11.015
11	Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501–1512 https://doi.org/10.1101/gad.13.12.1501
12	Verdin E, Hirschey MD, Finley LW, Haigis MC (2010) Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35:669–675 https://doi.org/10.1016/j.tibs.2010.07.003
13	Yang Y, Chen KY, Tong Q (2011) Murine Sirt3 protein isoforms have variable half-lives. Gene 488:46–51 https://doi.org/10.1016/j.gene.2011.07.029
14	Yu W, Dittenhafer-Reed KE, Denu JM (2012) SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem 287:14078–14086 https://doi.org/10.1074/jbc.M112.355206

[1]

PAC-0295-15256-DHT_suppl_1

Download

Viewed

Full text

Abstract

Cited

Shared

Discussed